Metraipolis › archive › dc_25df611cd71a

Targeting FGFR signaling overcomes therapeutic resistance and immune evasion in oncogenic PIK3CA-driven serous-like endometrial cancer — Europe PMC PMID:42082487

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42082487
DOI
10.1038/s41467-[numero omesso]-z
License (as archived)
solo-consultazione
Archived
2026-11-02T18:53:24.762Z
SHA-256 of the archived text
ced7cd2a30770f20ea2edb753874b31264a8f7f902c8f813e6b026b6b706f23e
Stable URL of this page
https://metraipolis.com/documento/dc_25df611cd71a

How to cite

Targeting FGFR signaling overcomes therapeutic resistance and immune evasion in oncogenic PIK3CA-driven serous-like endometrial cancer — Europe PMC PMID:42082487 — Europe PMC (en), https://europepmc.org/article/MED/42082487 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_25df611cd71a (Metraipolis archive dc_25df611cd71a, sha256 ced7cd2a30770f20ea2edb753874b31264a8f7f902c8f813e6b026b6b706f23e)
BibTeX
@misc{dc25df611cd71a,
  title = {Targeting FGFR signaling overcomes therapeutic resistance and immune evasion in oncogenic PIK3CA-driven serous-like endometrial cancer — Europe PMC PMID:42082487},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42082487},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_25df611cd71a; sha256 ced7cd2a30770f20ea2edb753874b31264a8f7f902c8f813e6b026b6b706f23e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42082487. Agents can read the archived copy with the MCP tool read_document.